;PMID: 10894600
;source_file_734.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:47..221] = [t:47..221]
;2)section:[e:225..356] = [t:225..356]
;3)section:[e:360..422] = [t:360..422]
;4)sentence:[e:426..511] = [t:426..511]
;5)sentence:[e:512..610] = [t:512..610]
;6)sentence:[e:611..676] = [t:611..676]
;7)sentence:[e:677..757] = [t:677..757]
;8)sentence:[e:758..967] = [t:758..967]
;9)sentence:[e:968..1085] = [t:968..1085]
;10)sentence:[e:1086..1225] = [t:1086..1225]
;11)sentence:[e:1226..1387] = [t:1226..1387]
;12)sentence:[e:1388..1469] = [t:1388..1469]
;13)sentence:[e:1470..1640] = [t:1470..1640]
;14)sentence:[e:1641..1797] = [t:1641..1797]
;15)section:[e:1801..1846] = [t:1801..1846]

;section 0 Span:0..42
;Am J Gastroenterol  2000 Jun;95(6):1576-80
(SEC
  (FRAG (NNP:[0..2] Am) (NNP:[3..4] J) (NNP:[5..18] Gastroenterol)
        (CD:[20..24] 2000) (.:[25..32] Jun;95-LRB-) (CD:[32..34] 6-RRB-)
        (CD:[34..39] :1576) (::[39..40] -) (CD:[40..42] 80)))

;sentence 1 Span:47..221
;Molecular and biological analysis of carcinoma of the small intestine: 
;beta-catenin gene mutation by interstitial deletion involving exon 3 and 
;replication error phenotype.
;[84..116]:malignancy:"carcinoma of the small intestine"
;[119..131]:gene-rna:"beta-catenin"
;[137..145]:variation-event:"mutation"
;[149..170]:variation-type:"interstitial deletion"
;[181..187]:variation-location:"exon 3"
(SENT
  (NP-HLN
    (NP
      (NP
        (NP (JJ:[47..56] Molecular)
          (NML-1 (-NONE-:[56..56] *P*)))
        (CC:[57..60] and)
        (NP (JJ:[61..71] biological)
          (NML-1 (NN:[72..80] analysis))))
      (PP (IN:[81..83] of)
        (NP
          (NP (NN:[84..93] carcinoma))
          (PP (IN:[94..96] of)
            (NP (DT:[97..100] the) (JJ:[101..106] small)
                (NN:[107..116] intestine))))))
    (::[116..117] :)
    (NP
      (NP (NN:[119..131] beta-catenin) (NN:[132..136] gene)
          (NN:[137..145] mutation))
      (PP (IN:[146..148] by)
        (NP
          (NP (JJ:[149..161] interstitial) (NN:[162..170] deletion))
          (VP (VBG:[171..180] involving)
            (NP
              (NP (NN:[181..185] exon) (CD:[186..187] 3))
              (CC:[188..191] and)
              (NP
                (NML (NN:[193..204] replication) (NN:[205..210] error))
                (NN:[211..220] phenotype)))))))
    (.:[220..221] .)))

;section 2 Span:225..356
;Murata M, Iwao K, Miyoshi Y, Nagasawa Y, Ohta T, Shibata K, Oda K, Wada H, 
;Tominaga S, Matsuda Y, Ohsawa M, Nakamura Y, Shimano T.
(SEC
  (FRAG (NNP:[225..231] Murata) (NNP:[232..234] M,) (NNP:[235..239] Iwao)
        (NNP:[240..241] K) (,:[241..242] ,) (NNP:[243..250] Miyoshi)
        (NNP:[251..252] Y) (,:[252..253] ,) (NNP:[254..262] Nagasawa)
        (NNP:[263..264] Y) (,:[264..265] ,) (NNP:[266..270] Ohta)
        (NNP:[271..272] T) (,:[272..273] ,) (NNP:[274..281] Shibata)
        (NNP:[282..283] K) (,:[283..284] ,) (NNP:[285..288] Oda)
        (NNP:[289..290] K) (,:[290..291] ,) (NNP:[292..296] Wada)
        (NNP:[297..298] H) (,:[298..299] ,) (NNP:[301..309] Tominaga)
        (NNP:[310..312] S,) (NNP:[313..320] Matsuda) (NNP:[321..322] Y)
        (,:[322..323] ,) (NNP:[324..330] Ohsawa) (NNP:[331..333] M,)
        (NNP:[334..342] Nakamura) (NNP:[343..344] Y) (,:[344..345] ,)
        (NNP:[346..353] Shimano) (NNP:[354..356] T.)))

;section 3 Span:360..422
;Department of Surgery, Ikeda Municipal Hospital, Osaka, Japan.
(SEC
  (FRAG (NNP:[360..370] Department) (IN:[371..373] of) (NNP:[374..381] Surgery)
        (,:[381..382] ,) (NNP:[383..388] Ikeda) (NNP:[389..398] Municipal)
        (NNP:[399..407] Hospital) (,:[407..408] ,) (NNP:[409..414] Osaka)
        (,:[414..415] ,) (NNP:[416..421] Japan) (.:[421..422] .)))

;sentence 4 Span:426..511
;The genetic mechanisms of carcinomas of the small intestine are not well 
;understood.
;[452..485]:malignancy:"carcinomas of the small intestine"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[426..429] The) (JJ:[430..437] genetic)
          (NNS:[438..448] mechanisms))
      (PP (IN:[449..451] of)
        (NP
          (NP (NNS:[452..462] carcinomas))
          (PP (IN:[463..465] of)
            (NP (DT:[466..469] the) (JJ:[470..475] small)
                (NN:[476..485] intestine))))))
    (VP (VBP:[486..489] are) (RB:[490..493] not)
      (ADVP (RB:[494..498] well))
      (VP (VBN:[500..510] understood)
        (NP-1 (-NONE-:[510..510] *))))
    (.:[510..511] .)))

;sentence 5 Span:512..610
;We report the results of analysis of genetic alterations in a case  of small
;intestinal carcinoma.
;[583..609]:malignancy:"small intestinal carcinoma"
(SENT
  (S
    (NP-SBJ (PRP:[512..514] We))
    (VP (VBP:[515..521] report)
      (NP
        (NP (DT:[522..525] the) (NNS:[526..533] results))
        (PP (IN:[534..536] of)
          (NP
            (NP (NN:[537..545] analysis))
            (PP (IN:[546..548] of)
              (NP (JJ:[549..556] genetic) (NNS:[557..568] alterations))))))
      (PP (IN:[569..571] in)
        (NP
          (NP (DT:[572..573] a) (NN:[574..578] case))
          (PP (IN:[580..582] of)
            (NP (JJ:[583..588] small) (JJ:[589..599] intestinal)
                (NN:[600..609] carcinoma))))))
    (.:[609..610] .)))

;sentence 6 Span:611..676
;A tumor in the terminal ileum was resected in a  59-yr-old woman.
;[613..640]:malignancy:"tumor in the terminal ileum"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[611..612] A) (NN:[613..618] tumor))
      (PP-LOC (IN:[619..621] in)
        (NP (DT:[622..625] the) (JJ:[626..634] terminal) (NN:[635..640] ileum))))
    (VP (VBD:[641..644] was)
      (VP (VBN:[645..653] resected)
        (NP-1 (-NONE-:[653..653] *))
        (PP-LOC (IN:[654..656] in)
          (NP (DT:[657..658] a)
            (ADJP
              (NML (CD:[660..662] 59) (HYPH:[662..663] -) (NN:[663..665] yr))
              (HYPH:[665..666] -) (JJ:[666..669] old))
            (NN:[670..675] woman)))))
    (.:[675..676] .)))

;sentence 7 Span:677..757
;Histologically, the tumor was classified as well-differentiated 
;adenocarcinoma.
;[697..702]:malignancy:"tumor"
;[721..756]:malignancy:"well-differentiated  adenocarcinoma"
(SENT
  (S
    (ADVP (RB:[677..691] Histologically))
    (,:[691..692] ,)
    (NP-SBJ-1 (DT:[693..696] the) (NN:[697..702] tumor))
    (VP (VBD:[703..706] was)
      (VP (VBN:[707..717] classified)
        (NP-1 (-NONE-:[717..717] *))
        (PP (IN:[718..720] as)
          (NP
            (ADJP (RB:[721..725] well) (HYPH:[725..726] -)
                  (VBN:[726..740] differentiated))
            (NN:[742..756] adenocarcinoma)))))
    (.:[756..757] .)))

;sentence 8 Span:758..967
;We screened for genetic alterations in adenomatous polyposis  coli (APC),
;beta-catenin, K-ras, and p53 genes, as well as microsatellite  instability,
;which are known to be involved in colorectal tumorigenesis.
;[797..824]:gene-rna:"adenomatous polyposis  coli"
;[826..829]:gene-rna:"APC"
;[832..844]:gene-rna:"beta-catenin"
;[846..851]:gene-rna:"K-ras"
;[857..860]:gene-rna:"p53"
(SENT
  (S
    (NP-SBJ (PRP:[758..760] We))
    (VP (VBD:[761..769] screened)
      (PP (IN:[770..773] for)
        (NP
          (NP (JJ:[774..781] genetic) (NNS:[782..793] alterations))
          (PP (IN:[794..796] in)
            (NP
              (NP
                (NP
                  (NP
                    (NML
                      (NML (JJ:[797..808] adenomatous) (NN:[809..818] polyposis)
                           (NN:[820..824] coli))
                      (NML (-LRB-:[825..826] -LRB-) (NN:[826..829] APC)
                           (-RRB-:[829..830] -RRB-)))
                    (NML-2 (-NONE-:[830..830] *P*)))
                  (,:[830..831] ,)
                  (NP (NN:[832..844] beta-catenin)
                    (NML-2 (-NONE-:[844..844] *P*)))
                  (,:[844..845] ,)
                  (NP (NN:[846..851] K-ras)
                    (NML-2 (-NONE-:[851..851] *P*)))
                  (,:[851..852] ,) (CC:[853..856] and)
                  (NP (NN:[857..860] p53)
                    (NML-2 (NNS:[861..866] genes))))
                (,:[866..867] ,)
                (CONJP (RB:[868..870] as) (RB:[871..875] well)
                       (IN:[876..878] as))
                (NP (NN:[879..893] microsatellite) (NN:[895..906] instability)))
              (,:[906..907] ,)
              (SBAR
                (WHNP-1 (WDT:[908..913] which))
                (S
                  (NP-SBJ-1 (-NONE-:[913..913] *T*))
                  (VP (VBP:[914..917] are)
                    (VP (VBN:[918..923] known)
                      (S
                        (NP-SBJ-1 (-NONE-:[923..923] *))
                        (VP (TO:[924..926] to)
                          (VP (VB:[927..929] be)
                            (VP (VBN:[930..938] involved)
                              (NP-1 (-NONE-:[938..938] *))
                              (PP-CLR (IN:[939..941] in)
                                (NP (JJ:[942..952] colorectal)
                                    (NN:[953..966] tumorigenesis))))))))))))))))
    (.:[966..967] .)))

;sentence 9 Span:968..1085
;The  tumor exhibited somatic interstitial deletion of 425-bp, which included
;the  entire exon 3 in beta-catenin gene.
;[973..978]:malignancy:"tumor"
;[997..1018]:variation-type:"interstitial deletion"
;[1057..1063]:variation-location:"exon 3"
;[1067..1079]:gene-rna:"beta-catenin"
(SENT
  (S
    (NP-SBJ (DT:[968..971] The) (NN:[973..978] tumor))
    (VP (VBD:[979..988] exhibited)
      (NP
        (NP
          (NP (JJ:[989..996] somatic)
             (JJ:[997..1009] interstitial) (NN:[1010..1018] deletion))
          (PP (IN:[1019..1021] of)
            (NP (NN:[1022..1028] 425-bp))))
        (,:[1028..1029] ,)
        (SBAR
          (WHNP-1 (WDT:[1030..1035] which))
          (S
            (NP-SBJ-1 (-NONE-:[1035..1035] *T*))
            (VP (VBD:[1036..1044] included)
              (NP (DT:[1045..1048] the) (JJ:[1050..1056] entire)
                 (NN:[1057..1061] exon) (CD:[1062..1063] 3))
              (PP-LOC (IN:[1064..1066] in)
                (NP (NN:[1067..1079] beta-catenin) (NN:[1080..1084] gene))))))))
    (.:[1084..1085] .)))

;sentence 10 Span:1086..1225
;Immunohistochemical staining confirmed  accumulation of aberrant beta-catenin
;protein in the cytoplasm and nuclei of the  malignant tissue.
;[1151..1163]:gene-protein:"beta-catenin"
;[1208..1224]:malignancy:"malignant tissue"
(SENT
  (S
    (NP-SBJ (JJ:[1086..1105] Immunohistochemical) (NN:[1106..1114] staining))
    (VP (VBD:[1115..1124] confirmed)
      (NP
        (NP (NN:[1126..1138] accumulation))
        (PP (IN:[1139..1141] of)
          (NP (JJ:[1142..1150] aberrant) (NN:[1151..1163] beta-catenin)
              (NN:[1164..1171] protein))))
      (PP-LOC (IN:[1172..1174] in)
        (NP
          (NP (DT:[1175..1178] the) (NN:[1179..1188] cytoplasm)
              (CC:[1189..1192] and) (NNS:[1193..1199] nuclei))
          (PP (IN:[1200..1202] of)
            (NP (DT:[1203..1206] the)
               (JJ:[1208..1217] malignant) (NN:[1218..1224] tissue))))))
    (.:[1224..1225] .)))

;sentence 11 Span:1226..1387
;Furthermore, a frameshift mutation in the transforming growth  factor beta
;receptor type II gene with replication error phenotype was detected  in the
;tumor DNA.
;[1241..1260]:variation-type:"frameshift mutation"
;[1281..1317]:gene-rna:"growth  factor beta receptor type II"
(SENT
  (S
    (ADVP (RB:[1226..1237] Furthermore))
    (,:[1237..1238] ,)
    (NP-SBJ-1
      (NP (DT:[1239..1240] a)
         (NN:[1241..1251] frameshift) (NN:[1252..1260] mutation))
      (PP (IN:[1261..1263] in)
        (NP
          (NP (DT:[1264..1267] the)
            (NML (VBG:[1268..1280] transforming) (NN:[1281..1287] growth)
                 (NN:[1289..1295] factor))
            (NML (SYM:[1296..1300] beta) (NN:[1301..1309] receptor))
            (NML (NN:[1310..1314] type) (CD:[1315..1317] II))
            (NN:[1318..1322] gene))
          (PP (IN:[1323..1327] with)
            (NP
              (NML (NN:[1328..1339] replication) (NN:[1340..1345] error))
              (NN:[1346..1355] phenotype))))))
    (VP (VBD:[1356..1359] was)
      (VP (VBN:[1360..1368] detected)
        (NP-1 (-NONE-:[1368..1368] *))
        (PP-LOC (IN:[1370..1372] in)
          (NP (DT:[1373..1376] the) (NN:[1377..1382] tumor)
              (NN:[1383..1386] DNA)))))
    (.:[1386..1387] .)))

;sentence 12 Span:1388..1469
;In contrast, no genetic alterations were found in the APC,  K-ras, and p53
;genes.
;[1442..1445]:gene-rna:"APC"
;[1448..1453]:gene-rna:"K-ras"
;[1459..1462]:gene-rna:"p53"
(SENT
  (S
    (PP (IN:[1388..1390] In)
      (NP (NN:[1391..1399] contrast)))
    (,:[1399..1400] ,)
    (NP-SBJ-2 (DT:[1401..1403] no) (JJ:[1404..1411] genetic)
              (NNS:[1412..1423] alterations))
    (VP (VBD:[1424..1428] were)
      (VP (VBN:[1429..1434] found)
        (NP-2 (-NONE-:[1434..1434] *))
        (PP-LOC (IN:[1435..1437] in)
          (NP (DT:[1438..1441] the)
            (NML
              (NML (NN:[1442..1445] APC)
                (NML-1 (-NONE-:[1445..1445] *P*)))
              (,:[1445..1446] ,)
              (NML (NN:[1448..1453] K-ras)
                (NML-1 (-NONE-:[1453..1453] *P*)))
              (,:[1453..1454] ,) (CC:[1455..1458] and)
              (NML (NN:[1459..1462] p53)
                (NML-1 (NNS:[1463..1468] genes))))))))
    (.:[1468..1469] .)))

;sentence 13 Span:1470..1640
;Our results suggested that both beta-catenin gene mutation  and replication
;error phenotype might contribute to carcinogenesis of the small  intestinal
;tumor in our case.
;[1502..1514]:gene-rna:"beta-catenin"
;[1604..1627]:malignancy:"small  intestinal tumor"
(SENT
  (S
    (NP-SBJ (PRP$:[1470..1473] Our) (NNS:[1474..1481] results))
    (VP (VBD:[1482..1491] suggested)
      (SBAR (IN:[1492..1496] that)
        (S
          (NP-SBJ (CC:[1497..1501] both)
            (NP (NN:[1502..1514] beta-catenin) (NN:[1515..1519] gene)
                (NN:[1520..1528] mutation))
            (CC:[1530..1533] and)
            (NP
              (NML (NN:[1534..1545] replication) (NN:[1546..1551] error))
              (NN:[1552..1561] phenotype)))
          (VP (MD:[1562..1567] might)
            (VP (VB:[1568..1578] contribute)
              (PP-CLR (TO:[1579..1581] to)
                (NP
                  (NP (NN:[1582..1596] carcinogenesis))
                  (PP (IN:[1597..1599] of)
                    (NP (DT:[1600..1603] the)
                      
                      (ADJP (JJ:[1604..1609] small) (JJ:[1611..1621] intestinal))
                      (NN:[1622..1627] tumor)))))
              (PP (IN:[1628..1630] in)
                (NP (PRP$:[1631..1634] our) (NN:[1635..1639] case))))))))
    (.:[1639..1640] .)))

;sentence 14 Span:1641..1797
;This is the first report that activation of  beta-catenin gene by somatic
;gene mutation is involved in the development of  carcinoma of the small
;intestine.
;[1686..1698]:gene-rna:"beta-catenin"
;[1764..1796]:malignancy:"carcinoma of the small intestine"
(SENT
  (S
    (NP-SBJ (DT:[1641..1645] This))
    (VP (VBZ:[1646..1648] is)
      (NP-PRD (DT:[1649..1652] the) (JJ:[1653..1658] first)
              (NN:[1659..1665] report)
        (SBAR (IN:[1666..1670] that)
          (S
            (NP-SBJ-1
              (NP (NN:[1671..1681] activation))
              (PP (IN:[1682..1684] of)
                (NP (NN:[1686..1698] beta-catenin) (NN:[1699..1703] gene)))
              (PP (IN:[1704..1706] by)
                (NP (JJ:[1707..1714] somatic) (NN:[1715..1719] gene)
                    (NN:[1720..1728] mutation))))
            (VP (VBZ:[1729..1731] is)
              (VP (VBN:[1732..1740] involved)
                (NP-1 (-NONE-:[1740..1740] *))
                (PP-CLR (IN:[1741..1743] in)
                  (NP
                    (NP (DT:[1744..1747] the) (NN:[1748..1759] development))
                    (PP (IN:[1760..1762] of)
                      (NP
                        (NP (NN:[1764..1773] carcinoma))
                        (PP (IN:[1774..1776] of)
                          (NP (DT:[1777..1780] the) (JJ:[1781..1786] small)
                              (NN:[1787..1796] intestine)))))))))))))
    (.:[1796..1797] .)))

;section 15 Span:1801..1846
;PMID: 10894600 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1801..1805] PMID) (::[1805..1806] :) (CD:[1807..1815] 10894600)
        (NN:[1816..1817] -LSB-) (NNP:[1817..1823] PubMed) (::[1824..1825] -)
        (NN:[1826..1833] indexed) (IN:[1834..1837] for)
        (NNP:[1838..1846] MEDLINE-RSB-)))
